Symbiosis to exhibit at Biotech Outsourcing Strategies (BOS)

Symbiosis will be attending and exhibiting at Biotech Outsourcing Strategies (BOS), 2013 (Discovery, Early Development & Clinical), on 17th September 2013 at the Royal College of Physicians, London. Please pop along or make an appointment via the BOS partnering software to meet with our experts and discuss how Symbiosis could accelerate the development of your injectable small molecule or biologic. See you… Read More

Symbiosis completes full clean room qualification

Symbiosis successfully completes the full qualification of its two sterile fill/finish and lyophilisation cleanroom suites.Symbiosis is delighted to announce that it has successfully completed the further qualification of its pharmaceutical manufacturing processes to cover an extensive range of vial sizes in both of its sterile fill/finish and lyophilzation cleanroom suites. Symbiosis has manufacturing suites dedicated to the sterile fill/finish of cytotoxic drugs and… Read More

Case study : Varleigh Immuno-Pharmaceuticals

Case Study March 2013Background and Challenges:VarleighImmuno-Pharmaceuticals Ltd. (Varleigh) is a British clinical stage biotechnology company focused on immune and inflammatory disorders. The company is focused on developing anti-complement and anti-inflammatory molecules as treatments for a range of conditions within the autoimmune and inflammatory diseases market.Varleigh’srecombinant protein drug product requiredcGMP manufacture under aseptic conditions to produce clinical supplies. Having previously suffered a total… Read More

Symbiosis launches new website!

On the 13th June, Symbiosis launched its new website, www.symbiosis-pharma.com to reflect its continued client focus and its growing international reputation as a world class cGMP manufacturer of sterile injectable pharmaceuticals for clinical trials.The new website offers users a more visually enhanced experience full of new images and better graphics such as a 3D animated “fly-through” of the Symbiosis manufacturing facility, generated from the… Read More

Symbiosis appoints new Business Development Manager

Symbiosis Pharmaceutical Services, a leading small-scale contract manufacturer of novel injectable pharmaceuticals for use in clinical trials, is pleased to announce the arrival of a new Business Development Manager, Joanne Anderson.With her employment we are strengthening our sales and marketing function. She will become a key point of communication for existing and new clients.She will be responsible for securing target sales through… Read More

Top 3 Reasons Why We’re Different!

By combining over 60 years of industry experience and by asking clients what was important to them before we built our facility, we identified the following:Flexibility – we can adapt our operational processes and systems to fit our clients’ project, and not the other way around. In practice that includes our approach to how we design and efficiently deliver our technical documentation and how we utilize our… Read More

Symbiosis is celebrating…

This month Symbiosis is celebrating its 2nd anniversary.As you can see from the photos below, we’ve come a long way!After listening to our clients we have developed a business that is focused on their needs.We have transformed a building site into a world class sterile manufacturing facility, been granted our GMP license and expanded our team to 20.Most importantly we have developed… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.